bafetinib,
INNO-406,
NS-187,
Bafetinib,
859212-16-1,
INNO-406,
NS-187,
UNII-NVW4Z03I9B,
INNO 406,
CNS-9,
NVW4Z03I9B,
INNO406,
CHEMBL206834,
(S)-N-(3-([4,5'-bipyrimidin]-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide,
4-[[(3S)-3-DIMETHYLAMINOPYRROLIDIN-1-YL]METHYL]-N-[4-METHYL-3-[(4-PYRIMIDIN-5-YLPYRIMIDIN-2-YL)AMINO]PHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE,
NS 187,
(S)-N-(3-(4,5'-bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide,
n-(3-((4,5'-bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3s)-3-(dimethylamino)-1-pyrrolidinyl)methyl)-3-(trifluoromethyl)benzamide,
N-[3-(4,5'-Bipyrimidin-2-Ylamino)-4-Methylphenyl]-4-{[(3s)-3-(Dimethylamino)pyrrolidin-1-Yl]methyl}-3-(Trifluoromethyl)benzamide,
Bafetinib [USAN:INN],
Bafetinib (USAN),
Bafetinib - INNO-406,
GTPL7906,
QCR-84,
SCHEMBL2684766,
SYN1179,
BCP22045,
EX-A1534,
BDBM50178612,
s1369,
ZINC22940637,
AN-3554,
CS-5142,
DB11851,
RL05315,
SB16616,
NCGC00386698-03,
AS-16314,
BC252523,
HY-50868,
FT-0662470,
A10119,
D10202,
212D161,
J-522973,
(S)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-N-(4-methyl-3-(4-(pyrimidin-5-yl)pyrimidin-2-ylamino)phenyl)-3-(trifluoromethyl)benzamide,
4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-N-(4-methyl-3-(4-(pyrimidin-5-yl)pyrimidin-2-ylamino)phenyl)-3-(trifluoromethyl)benzamide,
Benzamide, N-(3-((4,5'-bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3S)-3-(dimethylamino)-1-pyrrolidinyl)methyl)-3-(trifluoromethyl)-,
N-[3-([4,5'-bipyrimidin]-2-ylamino)-4-METhylphenyl]-4-[[(3S)-3-(dimethylamino)-1- pyrrolidinyl] methyl]-3-(trifluoromethyl)-benzamide,
N-[3-(4,5''-BIPYRIMIDIN-2-YLAMINO)-4-METHYLPHENYL]-4-{[(3S)-3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]METHYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,
Bafetinib [INN],
Bafetinib (INNO-406),
Lyn-IN-1,
D0G0VV,
C30H31F3N8O,
CID11387605,
CID 11387605,
4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide,